For the year ending 2025-12-27, FORM had -$90,159K decrease in cash & cash equivalents over the period. $11,740K in free cash flow.
| Cash Flow | 2025-12-27 |
|---|---|
| Net income | 54,361 |
| Depreciation and amortization | 37,589 |
| Accretion of discount on investments | 1,975 |
| Reduction in the carrying amount of right-of-use assets | 6,880 |
| Stock-based compensation expense | 38,576 |
| Deferred income tax provision (benefit) | 1,927 |
| Gain on sale of business | 103 |
| Provision for excess and obsolete inventories | 14,853 |
| Acquired inventory step-up amortization | 0 |
| Non-cash restructuring charges | 2,119 |
| Income (loss) from equity method investments | -2,026 |
| Foreign currency transaction losses | -2,110 |
| Other than temporary impairment on debt receivable | 0 |
| Accounts receivable | 20,156 |
| Inventories | 20,663 |
| Prepaid expenses and other current assets | -734 |
| Other assets | 483 |
| Accounts payable | -5,682 |
| Accrued liabilities | 4,601 |
| Other liabilities | 2,258 |
| Deferred revenues | 4,489 |
| Deferred grant | 0 |
| Operating lease liabilities | -8,063 |
| Net cash provided by operating activities | 115,398 |
| Acquisition of property, plant and equipment | 103,658 |
| Acquisition of business, net of cash acquired | 20,580 |
| Proceeds from sale of business and assets | 103 |
| Payments to acquire equity method investments | 67,156 |
| Purchase of promissory note receivable | 0 |
| Purchases of marketable securities | 126,307 |
| Proceeds from maturities and sales of marketable securities | 126,130 |
| Net cash provided by (used in) investing activities | -191,468 |
| Proceeds from issuances of common stock | 26,119 |
| Purchase of common stock through stock repurchase program, including excise tax paid | 26,244 |
| Tax withholdings related to net share settlements of equity awards | 12,402 |
| Payments on term loan | 1,106 |
| Net cash used in financing activities | -13,633 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -456 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -90,159 |
| Cash, cash equivalents and restricted cash, beginning of year | 197,206 |
| Cash, cash equivalents and restricted cash, end of year | 107,047 |
FORMFACTOR INC (FORM)
FORMFACTOR INC (FORM)